High Note Wealth’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$215K Sell
511
-3
-0.6% -$1.2K 0.04% 117
2026
Q2
$186K Sell
514
-5
-1% -$1.71K 0.03% 123
2026
Q1
$183K Buy
519
+11
+2% +$3.92K 0.04% 112
2025
Q4
$166K Buy
508
+28
+6% +$8.88K 0.03% 115
2025
Q3
$135K Buy
480
+1
+0.2% +$290 0.03% 122
2025
Q2
$134K Hold
479
– – 0.03% 121
2025
Q1
$149K Sell
479
-25
-5% -$7.38K 0.04% 110
2024
Q4
$131K Buy
+504
New +$150K 0.03% 117

Other funds holding AMGN

High Note Wealth's AMGN Position: Q3 2026 in Review

High Note Wealth reduced its Amgen (AMGN) stake by 0.58% in Q3 2026, selling an estimated $1.2K and leaving 511 shares worth $215K. The position accounts for 0.04% of the portfolio, ranked #117.

High Note Wealth first reported a position in AMGN in Q4 2024 and has held it in 8 quarters since. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • High Note Wealth held 511 shares of Amgen worth $215K as of Q3 2026.
  • High Note Wealth sold 3 Amgen shares in Q3 2026, an estimated $1.2K.
  • Amgen made up 0.04% of High Note Wealth's portfolio in Q3 2026, its #117 holding.
  • High Note Wealth first reported a position in Amgen in Q4 2024 and has held it in 8 quarters since.
  • 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on High Note Wealth's 13F filing for Q3 2026, filed 27 Oct 2026.